In Response: The path forward for the adverse outcome pathway framework-A regulatory perspective.

In this article the author discusses organizing biological knowledge in adverse outcome pathway (AOP) framework focusing on adverse health. Topics discussed include enhancing use of pathway-based data for regulatory decision making, transformation of AOP by the Organization for Economic Co-operation and Development (OECD) and, role of AOP to practice regulatory toxicology.